Skip to main content Skip to main navigation menu Skip to site footer
Journal of Commercial Biotechnology
  1. Home /
  2. Archives /
  3. Vol. 12 No. 1 (2005) /
  4. Editorial

Editorial: De-risking novel therapeutic development – time to stop blaming the molecule?

Authors

  • Simon Shohet

DOI:

https://doi.org/10.5912/jcb142

Abstract

 

 

Downloads

  • PDF

Issue

Vol. 12 No. 1 (2005)

Section

Editorial

Copyright © 2021
Journal of Commercial Biotechnology
All rights reserved.
ISSN: 1462-8732 | eISSN: 1478-565X

Privacy Policy

Journal of Commercial Biotechnology

GoDaddy SiteSeal WebTrust